KR101563997B1 - 진단 방법 - Google Patents

진단 방법 Download PDF

Info

Publication number
KR101563997B1
KR101563997B1 KR1020097025171A KR20097025171A KR101563997B1 KR 101563997 B1 KR101563997 B1 KR 101563997B1 KR 1020097025171 A KR1020097025171 A KR 1020097025171A KR 20097025171 A KR20097025171 A KR 20097025171A KR 101563997 B1 KR101563997 B1 KR 101563997B1
Authority
KR
South Korea
Prior art keywords
hbp
severe sepsis
risk
subject
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020097025171A
Other languages
English (en)
Korean (ko)
Other versions
KR20100021578A (ko
Inventor
라르스 비요르크
베르틸 크리스텐손
헤이코 헤르발트
아담 린데르
페르 아케손
Original Assignee
한사 메디컬 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101563997(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 한사 메디컬 에이비 filed Critical 한사 메디컬 에이비
Publication of KR20100021578A publication Critical patent/KR20100021578A/ko
Application granted granted Critical
Publication of KR101563997B1 publication Critical patent/KR101563997B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
KR1020097025171A 2007-06-12 2008-06-12 진단 방법 Active KR101563997B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0711327.7 2007-06-12
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method

Publications (2)

Publication Number Publication Date
KR20100021578A KR20100021578A (ko) 2010-02-25
KR101563997B1 true KR101563997B1 (ko) 2015-10-28

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097025171A Active KR101563997B1 (ko) 2007-06-12 2008-06-12 진단 방법

Country Status (16)

Country Link
US (3) US8518648B2 (enExample)
EP (1) EP2129391B1 (enExample)
JP (1) JP5166522B2 (enExample)
KR (1) KR101563997B1 (enExample)
CN (2) CN101687023B (enExample)
AT (1) ATE548050T1 (enExample)
AU (1) AU2008261252B2 (enExample)
BR (1) BRPI0812875B8 (enExample)
CA (1) CA2690067C (enExample)
DK (1) DK2129391T3 (enExample)
ES (1) ES2380875T3 (enExample)
GB (1) GB0711327D0 (enExample)
PL (1) PL2129391T3 (enExample)
PT (1) PT2129391E (enExample)
SI (1) SI2129391T1 (enExample)
WO (1) WO2008151808A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
CA2818887A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
WO2013040379A1 (en) * 2011-09-16 2013-03-21 Cepheid Methods of detecting sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2016057945A1 (en) 2014-10-09 2016-04-14 Texas Tech University System Micro-device to detect infection
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
WO2020218121A1 (ja) 2019-04-24 2020-10-29 公益財団法人がん研究会 癌を検出する方法および検出試薬
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170745A1 (en) 2002-03-08 2003-09-11 Pereira Heloise Anne Early detection marker for chronic inflammatory associated diseases
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
FI964227L (fi) 1994-04-21 1996-10-21 Novo Nordisk As Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
AU2003261387A1 (en) * 2003-02-24 2004-09-17 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
CA2529503A1 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
JP2008538007A (ja) * 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
CA2624569A1 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170745A1 (en) 2002-03-08 2003-09-11 Pereira Heloise Anne Early detection marker for chronic inflammatory associated diseases
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Annals of Surgery,195권,1호,19-24면(1982)

Also Published As

Publication number Publication date
CN103543271A (zh) 2014-01-29
CN101687023B (zh) 2016-04-20
CA2690067A1 (en) 2008-12-18
ES2380875T3 (es) 2012-05-21
US20100305185A1 (en) 2010-12-02
PT2129391E (pt) 2012-06-06
BRPI0812875B8 (pt) 2022-07-12
BRPI0812875B1 (pt) 2017-12-05
JP5166522B2 (ja) 2013-03-21
US20140187503A1 (en) 2014-07-03
PL2129391T3 (pl) 2012-09-28
SI2129391T1 (sl) 2012-07-31
JP2010529468A (ja) 2010-08-26
GB0711327D0 (en) 2007-07-25
AU2008261252B2 (en) 2013-03-14
CN101687023A (zh) 2010-03-31
BRPI0812875A2 (pt) 2014-12-09
AU2008261252A1 (en) 2008-12-18
EP2129391A1 (en) 2009-12-09
US8518648B2 (en) 2013-08-27
KR20100021578A (ko) 2010-02-25
US20130252347A1 (en) 2013-09-26
DK2129391T3 (da) 2012-06-11
ATE548050T1 (de) 2012-03-15
EP2129391B1 (en) 2012-03-07
CA2690067C (en) 2023-09-19
US9784741B2 (en) 2017-10-10
WO2008151808A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
KR101563997B1 (ko) 진단 방법
JP4911600B2 (ja) サンプル中の可溶性のｔｒｅｍ−１レベルを測定することによって伝染病を診断する方法
AU2011332241B2 (en) Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
US20080031874A1 (en) Treatment of endotoxemia using endotoxin neutralizing agents
US9759720B2 (en) Diagnostic method for bacterial meningitis
EP1295127B1 (en) Inter-alpha-trypsin as a marker for sepsis
Komaru et al. Nephritis-associated plasmin receptor (NAPlr) positive glomerulonephritis caused by Aggregatibacter actinomycetemcomitans bacteremia: A case report
CN115975025B (zh) C反应蛋白（crp）检测试剂盒
US20240272178A1 (en) A method for predicting sepsis and septic shock
CN116063482B (zh) C反应蛋白(crp)尿液检测试剂盒
US20220357344A1 (en) Prognosis prediction method of idiopathic pulmonary fibrosis
Arica et al. P798 The investigation of correlation between serum cytokine levels, C-reactive protein and erythrocyte sedimentation rate in acute brucellosis

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20091202

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130604

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141103

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20150727

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20151022

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20151023

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20180918

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20180918

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20190917

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20190917

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20200928

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20210915

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20230918

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20240919

Start annual number: 10

End annual number: 10